NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live OS Therapies Incorporated Share Price Chart

O H L

OS Therapies Incorporated Performance Overview

Days Range
$1.78Low
$1.83High

Markets Today

Previous Close$1.83
Open$1.83
Volume126,104
Day's Range$1.78 - $1.83
52W Range$1.15 - $2.25
Market Cap$81.91 M

Historical Performance

1M Returns+27.08
3M Returns-5.18
6M Returns+21.19
1Y Returns-17.19
5Y ReturnsNA
10Y ReturnsNA

OS Therapies Incorporated Fundamentals

Market Cap$81.91 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$-1.07
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-28.34 M
Profit MarginN/A
Market Cap$81.91 M
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTMN/A
EPS TTM$-1.07
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDA$-28.34 M
Profit MarginN/A

OS Therapies Incorporated Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$5.00 M-$4.84 M-$6.88 M-$11.99 M-$10.17 M-$8.58 M
EBITDA -$5.00 M-$4.73 M-$6.75 M-$11.86 M-$10.04 M-$8.45 M
Interest Expense $0$0$0$0-$75.34 K-$5.58 K
Depreciation $695$112.51 K$124.94 K$124.94 K$124.94 K$124.94 K
Income Before Tax -$3.88 M-$4.54 M-$6.88 M-$13.46 M-$10.40 M-$8.63 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$3.88 M-$4.54 M-$6.88 M-$13.46 M-$10.40 M-$8.63 M
Net Profit Margin ------

OS Therapies Incorporated Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $21.35 K$29.66 K$33.27 K$37.11 K$39.28 K$45.28 K
Reserve & Surplus -$42.31 M-$46.85 M-$53.73 M-$67.19 M-$77.58 M-$86.22 M
Non-Current Liabilities $100.00 K$100.00 K$100.00 K$100.00 K$100.00 K$100.00 K
Current Liabilities $3.54 M$3.46 M$4.15 M$11.76 M$16.95 M$20.64 M
Total Liabilities $3.64 M$3.56 M$4.25 M$11.86 M$17.05 M$20.74 M
Fixed Assets $4.58 K$3.88 K$3.19 K$2.49 K$1.79 K$1.10 K
Current Assets $4.10 M$3.55 M$2.32 M$332.91 K$917.55 K$3.64 M
Total Assets $4.25 M$10.31 M$8.95 M$6.84 M$7.30 M$9.90 M

OS Therapies Incorporated Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$3.88 M-$4.54 M-$6.88 M-$13.46 M-$10.40 M-$8.63 M
Operating Cash Flow -$3.44 M-$2.36 M-$4.71 M-$3.73 M-$4.56 M-$5.53 M
Investing Cash Flow -$173.64 K-$292.79 K$0$0$0$0
Financing Cash Flow $1.05 M$2.48 M$3.78 M$2.12 M$5.21 M$4.82 M
Change in Cash -$2.56 M-$168.99 K-$925.39 K-$1.61 M$647.72 K-$712.52 K

OS Therapies Incorporated Return Calculator

The OS Therapies Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About OS Therapies Incorporated

OS Therapies Inc is a clinical stage biopharmaceutical company focused on the identification, development and commercialization of treatments for Osteosarcoma (OS) and other solid tumors. The company's mission is to address the need for new treatments in cancers of the bone in children and young adults. The company has pipeline of product candidates targeting multiple indications for solid cancers including two drug technologies: (i) OST-HER2, an off-the-shelf immunotherapy, which is a type of cancer treatment that helps the immune system fight cancer and OST-tADC which is a tunable drug conjugate (tADC) platform currently in preclinical development. Each tADC contains four main components: ligand, payload cassette adaptor, linker and payload.

FAQs

OS Therapies Incorporated (OSTX) share price as of September 18, 2026 is $1.77. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the OS Therapies Incorporated (OSTX) Share by opening an international trading account with Angel One.
Purchasing OS Therapies Incorporated (OSTX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying OS Therapies Incorporated (OSTX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of OS Therapies Incorporated (OSTX) or any other US company shares in Angel One for any dollar amount.
The market capitalization of OS Therapies Incorporated on September 18, 2026, is $81.91 M.
OS Therapies Incorporated operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in OS Therapies Incorporated (OSTX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91